{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-028901","form_type":"8-K","ticker":null,"cik":"0001837344","company_name":"Nocturne Acquisition Corp","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.608624+00:00","generated_at":"2026-06-04T04:53:28.830887+00:00","sec_items":["1.01","3.01","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Nocturne Acquisition merger with Cognos expires; Nasdaq delisting notice received, meeting canceled","bullets":["Merger agreement with Cognos Therapeutics expired automatically on March 31, 2024, after Outside Date passed without closing.","Nasdaq notified Nocturne on March 26, 2024 of non-compliance with SPAC listing rule; delisting effective April 4, 2024 as no hearing requested.","Extraordinary General Meeting for the business combination, previously postponed to April 2, 2024, has been canceled permanently.","Company intends to allow its securities to be delisted from Nasdaq; no further merger vote will occur."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-028901","json":"https://secwatch.observer/filing/0001213900-24-028901.json","markdown":"https://secwatch.observer/filing/0001213900-24-028901.md","text":"https://secwatch.observer/filing/0001213900-24-028901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1837344/000121390024028901/0001213900-24-028901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1837344/000121390024028901/ea0203100-8k425_nocturne.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:53:28.830887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"aa6c58de9740c976846e748651cd2d1141827f73","claim":"Nocturne Acquisition Corp terminated Agreement and Plan of Merger and Reorganization with Cognos Therapeutics, Inc. (effective 2024-03-31).","evidence_excerpt":"f Nocturne (“Merger Sub”), and Cognos Therapeutics, Inc., a Delaware corporation (“Cognos”), with respect to a proposed initial business combination (such proposed business combination the “Merger”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1837344/000121390024028901/0001213900-24-028901-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Cognos Therapeutics, Inc."},{"label":"Effective","value":"2024-03-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}